erythromycin A9-oxime (E) (3 R ,4 S ,5 S ,6 R ,7 R ,9 R ,11 R ,12 R ,13 S ,14 R )-4-((2,6-didesoxy-3- C -methyl-3- O -methyl-α- L -ribo-hexopiranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-tridesoxy-3-dimethylamino-β-.sc.d.sc.-xylohexapiranosyl)oxy)oxacyclotetradecan-2-ona-10-oxime (E) 603-225-00-8
Name
erythromycin A9-oxime (E) (3 R ,4 S ,5 S ,6 R ,7 R ,9 R ,11 R ,12 R ,13 S ,14 R )-4-((2,6-didesoxy-3- C -methyl-3- O -methyl-α- L -ribo-hexopiranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-tridesoxy-3-dimethylamino-β-.sc.d.sc.-xylohexapiranosyl)oxy)oxacyclotetradecan-2-ona-10-oxime (E) 603-225-00-8
Molecular Formula
C37H68N2O13
Identifiers
GHS Hazard Pictograms
Hazard Classifications
Disclaimer
The substance data provided is sourced from various third-party databases and regulatory sources. While we strive to maintain accuracy, we cannot guarantee the completeness, accuracy, or timeliness of this information. Users are responsible for verifying all data before use in compliance, safety, or regulatory contexts. NextSDS is not liable for any decisions made based on this data.